Table 1.

Correlation of CCL18 Expressing TAM Counts with Clinicopathological Status in 562 Cases of Patients with Breast Cancer

CCL18+ TAM Counts	≤5	6–20	>20	p Value
Age (years)
≤45	126	75	69
>45	106	99	87	0.716
Tumor Size (cm)
≤2	126	75	69
>2	106	98	88	0.044
Stage
0	46	10	1
I	73	13	1
II	107	97	92
III	6	53	63	<0.001
Histological Gradea
I	45	46	17
II	72	60	64
III	69	57	75	0.002
Metastasisb
Lung	2	4	7
Liver	0	13	12
Bone	4	25	27
Brain	1	3	7	0.014
Lymph Node Metastasis
0	165	33	17
1–3	58	84	70
≥4	9	56	70	<0.01
LVI
(+)	32	61	91
(−)	200	112	66	<0.001
ER
(+)	162	129	120
(−)	70	44	37	0.31
Her2
(+)	34	25	41
(−)	197	147	117	0.007
CCL5
(−)	59	44	45
(+)	61	53	39
(++)	68	47	35
(+++)	44	28	39	0.364
CD4+ T Lymphocytesc
Low	90	58	46
Media	88	57	53
High	54	58	58	0.036
CD8+ T Lymphocytesc
Low	85	49	55
Media	74	66	58
High	73	57	45	0.414

See also Tables S1–S3.

^aGrading in 505 cases of invasive ductal carcinoma.

^bDistant metastasis identified during postoperative follow-up.

^cPercent volume of CD4⁺/CD8⁺ T lymphocytes.